AI Innovation for Automated Detection and Classification of Osteoporotic Fractures of the Spine in CT Scans | ImageBiopsy Lab launches IB Lab FLAMINGO

ImageBiopsy Lab, a pioneer in medical imaging, introduces IB Lab FLAMINGO at this year’s RSNA conference.  The fully automated software identifies asymptomatic spinal fractures in CT scans. Utilizing the gold standard Genant classification, IB Lab FLAMINGO highlights relevant fractures and empowers proactive treatment for healthcare professionals.

“Our partnership with UCB highlights the potential of leveraging AI for improving care for many diseases, including osteoporosis” explains Richard Ljuhar, CEO at ImageBiopsy Lab.

Understanding the Osteoporosis Challenge

“Together with expert clinicians, UCB developed this deep-learning computational model that can detect vertebral compression fractures on CT scans. ImageBiopsy Lab as a musculoskeletal (MSK) radiology AI company has refined the technology and is now ready to integrate it into clinical care. Given that 80% of fragility fractures today remain undiagnosed and untreated, we’re excited about the potential of IB Lab FLAMINGO to help close the global treatment gap in osteoporosis”, said Jen Timoshanko, Head of Medical Affairs, Bone Health Mission at UCB.

Osteoporosis impacts around 200 million globally, leading to 9 million fragility fractures annually, most of them vertebral (VFs). Its silent progression can cause pain, reduced mobility, and diminished quality of life. Apart from personal suffering, fragility fractures strain global public health systems, escalating treatment costs and mortality rates, posing societal challenges.

“In an ageing society, osteoporosis and its consequences, especially geriatric fractures, challenge patients, physicians, and healthcare systems. IB Lab FLAMINGO’s ability to detect vertebral fractures offers a crucial, automated solution for early risk assessment and targeted treatment in addressing osteoporosis complexities.” Prof. Andreas Kurth, Director of the Center for Orthopaedics and Trauma Surgery at Marienhaus Klinikum Mainz, Germany, expressed the need for a meaningful solution.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

“Working closely with leading interventionists, we designed the latest Azurion neuro biplane to meet their requirements of superior patient care, optimized angio suite performance, and efficient return on investment.  Together, I am confident we can continue to reduce the impact of stroke, helping more patients to recover faster and reducing long-term impact on their health," said Mark Stoffels, Business Leader of Image Guided Therapy Systems at Philips.
LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy